Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Modern Rheumatology|November 15, 2018
IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive reviewAtsushi Ogata, Yasuhiro Kato, Shinji Higa, et al.
Expert Opinion on Drug Delivery|May 16, 2019
Subcutaneous tocilizumab: recent advances for the treatment of rheumatoid arthritisAtsushi Ogata, Yasuhiro Kato, Shinji Higa, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2003
Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophilsShinji Higa, Toru Hirano, Mayumi Kotani, et al.
Internal Medicine (Tokyo, Japan)|June 13, 2002
Autoimmune acquired form of angioedema that responded to danazol therapyShinji Higa, Haruhiko Hirata, Seigou Minami, et al.
Cureus|January 2, 2026
A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two PatientsTomohiro Koga, Remi Sumiyoshi, Toshimasa Shimizu, et al.
Modern Rheumatology Case Reports|May 13, 2023
Spontaneous resolution of inflammatory myopathy involving the masseter muscle following COVID-19 mRNA vaccinationTomomi Tada, Haruka Murao, Reo Shiratani, et al.
Modern Rheumatology Case Reports|October 22, 2020
Autoimmune myelofibrosis associated with systemic lupus erythematosus: a case reportTansri Wibowo, Shoji Kawada, Yutaka Ishida, et al.
International Archives of Allergy and Immunology|May 22, 2004
Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophilsToru Hirano, Shinji Higa, Junsuke Arimitsu, et al.
Modern Rheumatology|April 13, 2011
A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatmentHideko Nakahara, Yosuke Kamide, Yoshimasa Hamano, et al.
International Archives of Allergy and Immunology|April 8, 2006
Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophilsToru Hirano, Junsuke Arimitsu, Shinji Higa, et al.
Pageof 2